Acura Pharmaceuticals, Inc.
OTC: ACUR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Robert Jones
- Employees
- 9
- Headquarters
- Palatine, United States
- IPO year
- 1986
- Market cap
- $26.4K
- Website
- https://www.acurapharm.com
Loading ACUR…
Loading profile data…Frequently asked questions about ACUR
What does Acura Pharmaceuticals, Inc. (ACUR) do?
Acura Pharmaceuticals, Inc. operates as a drug delivery innovator, dedicated to exploring, developing, and bringing to market novel technologies and products aimed at enhancing medication safety across the United States. Its product portfolio features Oxaydo tablets, a potent Schedule II narcotic prescribed for managing both acute and chronic mo...
Where does ACUR trade?
Acura Pharmaceuticals, Inc. (ACUR) trades on the Other OTC.
What sector is ACUR in?
Acura Pharmaceuticals, Inc. (ACUR) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Acura Pharmaceuticals, Inc.?
Robert Jones is the chief executive officer of Acura Pharmaceuticals, Inc. (ACUR).
Where is Acura Pharmaceuticals, Inc. headquartered?
Acura Pharmaceuticals, Inc. is headquartered in United States.
Does ACUR pay a dividend?
Acura Pharmaceuticals, Inc. (ACUR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACUR go public?
Acura Pharmaceuticals, Inc. (ACUR) completed its initial public offering in 1986.